E
Evangelos Dimakakos
Researcher at National and Kapodistrian University of Athens
Publications - 47
Citations - 3446
Evangelos Dimakakos is an academic researcher from National and Kapodistrian University of Athens. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 12, co-authored 36 publications receiving 2402 citations. Previous affiliations of Evangelos Dimakakos include University of the West.
Papers
More filters
Journal ArticleDOI
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
Behnood Bikdeli,Mahesh V. Madhavan,David Jiménez,Taylor Chuich,Isaac Dreyfus,Elissa Driggin,Caroline Der Nigoghossian,Walter Ageno,Mohammad Madjid,Yutao Guo,Liang V. Tang,Yu Hu,Jay Giri,Mary Cushman,Isabelle Quéré,Evangelos Dimakakos,C. Michael Gibson,C. Michael Gibson,Giuseppe Lippi,Emmanuel J. Favaloro,Jawed Fareed,Joseph A. Caprini,Alfonso Tafur,John R. Burton,Dominic P. Francese,Elizabeth Y. Wang,Anna Falanga,Claire McLintock,Beverley J. Hunt,Alex C. Spyropoulos,Geoffrey D. Barnes,John W. Eikelboom,John W. Eikelboom,Ido Weinberg,Sam Schulman,Marc Carrier,Gregory Piazza,Gregory Piazza,Joshua A. Beckman,P. Gabriel Steg,Gregg W. Stone,Stephan Rosenkranz,Samuel Z. Goldhaber,Samuel Z. Goldhaber,Sahil A. Parikh,Manuel Monreal,Harlan M. Krumholz,Stavros Konstantinides,Jeffrey I. Weitz,Gregory Y.H. Lip,Gregory Y.H. Lip +50 more
TL;DR: The current understanding of the pathogenesis, epidemiology, management and outcomes of patients with COVID-19 who develop venous or arterial thrombosis, and of those with preexistingThrombotic disease who develop CO VID-19 are reviewed.
Journal ArticleDOI
Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action.
Anastasios Kollias,Konstantinos G. Kyriakoulis,Evangelos Dimakakos,Garyphallia Poulakou,George S. Stergiou,Konstantinos N. Syrigos +5 more
TL;DR: Preliminary data show that in patients with severe COVID‐19, anticoagulant therapy appears to be associated with lower mortality in the subpopulation meeting sepsis‐induced coagulopathy criteria or with markedly elevated d‐dimer.
Journal ArticleDOI
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research.
Behnood Bikdeli,Behnood Bikdeli,Mahesh V. Madhavan,Aakriti Gupta,Aakriti Gupta,David Jiménez,John R. Burton,Caroline Der Nigoghossian,Taylor Chuich,Shayan Nabavi Nouri,Isaac Dreyfus,Elissa Driggin,Sanjum S. Sethi,Kartik Sehgal,Kartik Sehgal,Saurav Chatterjee,Walter Ageno,Mohammad Madjid,Yutao Guo,Yutao Guo,Liang V. Tang,Yu Hu,Laurent Bertoletti,Jay Giri,Jay Giri,Jay Giri,Mary Cushman,Isabelle Quéré,Evangelos Dimakakos,C. Michael Gibson,C. Michael Gibson,Giuseppe Lippi,Emmanuel J. Favaloro,Jawed Fareed,Alfonso Tafur,Alfonso Tafur,Dominic P. Francese,Jaya Batra,Anna Falanga,Kevin J. Clerkin,Nir Uriel,Ajay J. Kirtane,Claire McLintock,Beverley J. Hunt,Alex C. Spyropoulos,Geoffrey D. Barnes,John W. Eikelboom,Ido Weinberg,Sam Schulman,Sam Schulman,Marc Carrier,Gregory Piazza,Gregory Piazza,Joshua A. Beckman,Martin B. Leon,Gregg W. Stone,Stephan Rosenkranz,Samuel Z. Goldhaber,Samuel Z. Goldhaber,Sahil A. Parikh,Manuel Monreal,Harlan M. Krumholz,Stavros Konstantinides,Jeffrey I. Weitz,Gregory Y.H. Lip,Gregory Y.H. Lip +65 more
TL;DR: Novel dosing approaches are described for commonly used antithrombotic agents (especially heparin-based regimens) and the potential use of less widely used antithsombotic drugs in the absence of confirmed thrombosis.
Journal ArticleDOI
Guidance for the management of patients with vascular disease or cardiovascular risk factors and COVID-19 position paper from vas-european independent foundation in angiology/vascular medicine
Grigoris T. Gerotziafas,Mariella Catalano,Mary-Paula Colgan,Zsolt Pecsvarady,Jean-Claude Wautrecht,Bahare Fazeli,D. Olinic,Katalin Farkas,Ismail Elalamy,Ismail Elalamy,Anna Falanga,Jawed Fareed,Chryssa Papageorgiou,Rosella S. Arellano,Petros Agathagelou,Darco Antic,Luciana Auad,Ljiljana Banfić,John R. Bartolomew,Bela Benczur,Melissa B. Bernardo,Francesco Boccardo,Renate Cifkova,Benilde Cosmi,Sergio De Marchi,Evangelos Dimakakos,Meletios A. Dimopoulos,Gabriel Dimitrov,Isabelle Durand-Zaleski,Michael Edmonds,Essam Abo El Nazar,Dilek Erer,Omar L. Esponda,Paolo Gresele,Michael Gschwandtner,Yongquan Gu,Mónica Heinzmann,Naomi M. Hamburg,Amer Hamadé,Noor-Ahmed Jatoi,Oguz Karahan,Debora Karetová,Thomas Karplus,Peter Klein-Weigel,Endre Kolossváry,Matija Kozak,Eleftheria Lefkou,Gianfranco Lessiani,Aaron Liew,Antonella Marcoccia,Peter Marshang,George Marakomichelakis,Jiri Matuska,Luc Moraglia,Sergio Pillon,Pavel Poredos,Manlio Prior,David Raymund K. Salvador,Oliver Schlager,Gerit Schernthaner,Alexander Sieron,Alexander Sieron,Jonas Spaak,Alex C. Spyropoulos,Muriel Sprynger,Dušan Šuput,Agata Stanek,Viera Štvrtinová,Andrzej Szuba,Alfonso Tafur,P Vandreden,Panagiotis Vardas,Dragan Vasic,Miikka Vikkula,Paul W. Wennberg,Zhenguo Zhai,Zhenguo Zhai +76 more
TL;DR: The VAS-European Independent Foundation in Angiology/Vascular Medicine draws attention to patients with vascular disease (VD) and presents an integral strategy for the management of patients with VD or cardiovascular risk factors (VD-CVR) and COVID-19.
Journal ArticleDOI
ESVM Guideline on peripheral arterial disease.
Ulrich Frank,Sigrid Nikol,Jill J. F. Belch,Vinko Boc,Marianne Brodmann,Patrick H. Carpentier,Ali Chraim,Caitriona Canning,Evangelos Dimakakos,Anders Gottsäter,Christian Heiss,Lucia Mazzolai,Juraj Madaric,D. Olinic,Zsolt Pecsvarady,Pavel Poredos,Isabelle Quéré,Karel Roztocil,Agata Stanek,Dragan Vasic,Adriana Visonà,Jean-Claude Wautrecht,Miroslav Bulvas,Mary-Paula Colgan,Walter Dorigo,Graeme Houston,Thomas Kahan,Holger Lawall,Isak Lindstedt,Guillaume Mahé,Romeo Martini,Giles Pernod,Stanisław Przywara,Marc Philip Righini,Oliver Schlager,Piotr Terlecki +35 more